In vitro and in vivo TNFa synthesis modulation by methylguanidine, an uremic catabolyte

dc.contributor.author	Autore, G.
dc.contributor.author	Marzocco, S.
dc.contributor.author	Sorrentino, R.
dc.contributor.author	Mirone, V. G.
dc.contributor.author	Baydoun, A. R.
dc.contributor.author	Pinto, A.
dc.date.accessioned	2008-02-28T10:05:37Z
dc.date.available	2008-02-28T10:05:37Z
dc.date.issued	1999
dc.identifier.citation	Autore , G , Marzocco , S , Sorrentino , R , Mirone , V G , Baydoun , A R & Pinto , A 1999 , ' In vitro and in vivo TNFa synthesis modulation by methylguanidine, an uremic catabolyte ' , Life Sciences , vol. 65 , no. 11 . https://doi.org/10.1016/S0024-3205(99)00355-0
dc.identifier.issn	0024-3205
dc.identifier.other	dspace: 2299/1708
dc.identifier.uri	http://hdl.handle.net/2299/1708
dc.description	Original article can be found at: http://www.sciencedirect.com/science/journal/00243205 Copyright Elsevier Inc.
dc.description.abstract	We have investigated whether methylguanidine (MG), an uremic toxin, modulates the expression of the inducible nitric oxide synthase (iNOS) and nitric oxide (NO) release in vitro in LPS-induced J774 macrophages.	en
dc.format.extent	85299
dc.language.iso	eng
dc.relation.ispartof	Life Sciences
dc.title	In vitro and in vivo TNFa synthesis modulation by methylguanidine, an uremic catabolyte	en
dc.contributor.institution	Department of Human and Environmental Sciences
dc.description.status	Peer reviewed
rioxxterms.versionofrecord	10.1016/S0024-3205(99)00355-0
rioxxterms.type	Journal Article/Review
herts.preservation.rarelyaccessed	true